Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., October 13, 2021.
Brendan McDermid | Reuters
Earnings season is winding down, but there are some buzzy names left to report.
Biogen and Lilly: How I’m Playing the Alzheimer’s Drug Stocks Game
Eureka!?! Cambridge, Massachusetts-based biotech Biogen ( BIIB) and Japanese drug maker Eisai ( ESALY) reported on Wednesday morning that their...
Read more